Canadian Cancer Survivor Network – The Canadian Cancer Survivor Network was created by a group of Canadians concerned about cancer.

View our webinars

Catch up on all our webinars

View it Here

Upcoming Events

Feb06
Better Breathing Week
Better Breathing Week is the Lung Health Foundation’s marquee annual event and represents their work in the national lung health space. Celebrating 40 years, this year’s conference will bring together a community of healthcare professionals, people with lived experience, policy makers and more for a week filled with: Informative educational sessions Thought-provoking ideas for practice change Powerful discussions on key policy issues impacting Canadians
View Event
Feb07
Rally for public health care at Trudeau-Premiers meeting
Prime Minister Justin Trudeau and the Premiers will be discussing health care on February 7 in Ottawa. Join us outside that meeting to send a loud message to our leaders: our public health care system needs to be protected and expanded. 12:00-1:00 PM ET Terry Fox Statue Wellington & Metcalfe, Ottawa
View Event
Feb07
Lung Health Foundation’s Better Breathing Week
Registration for the Lung Health Foundation’s Better Breathing Week is now OPEN. An educational adventure where you can make new connections and help create a world where everyone can breathe better. Sessions run February 7-10, 2023. Here’s a sneak peak at some of our Friday highlights featuring speakers from across Canada: Patient-Oriented Research and Its Implications on Indigenous Respiratory Health with Malcolm King, PhD, FCAHS,
View Event
Feb08
PMPRB Webinar: CompassRx, 8th Edition
This event is put on by the PMPRB NPDUIS As part of the National Prescription Drug Utilization Information System (NPDUIS) research initiative, the Patented Medicine Prices Review Board has just released the seventh edition of CompassRx, a series that monitors and analyzes the cost pressures driving changes in prescription drug expenditures in Canadian public drug plans. This edition provides insight into the factors driving the
View Event
Feb09
What to say when you don’t know what to say: Navigating Challenging Conversations
This event is put on by the West Island Cancer Wellness Centre. Sometimes, we just do not know what to say to someone living with cancer. We can feel as though we might say something wrong, so better to say nothing. Sound familiar? If so, this amazing Zoom into Wellness session is for you.
View Event

Participate

CTO’s decentralized clinical trials survey
CTO launched a survey related to potential participants' thoughts and preferences related to decentralized or hybrid clinical trials. This type of survey has not yet been done in Canada and will provide us with evidence about how Canadians may prefer to participate in clinical trials. The data will help inform us and tell us how we might best work with our community around these preferences. We collaborated with our College of Lived Experience to develop the survey. We plan to share results with the community and to develop tools/resources based on these results. The survey is open to any Canadian over 18 years - it doesn't matter what your background is, if you've participated in a clinical trial or not, if you work in research, etc.Participate Now
Assessing Patient Awareness and Satisfaction about the Information Received by Health-Care Providers on the Potential Risks of Cancer-Associated Venous Thromboembolism and Anticoagulation
A Global Initiative for World Thrombosis Day 2022. This survey has been created to evaluate patient knowledge and satisfaction with the information given to them regarding the potential risks of cancer- associated venous thromboembolism and anticoagulation.THROMBOSISParticipate Now
Mesothelioma Applied Research Foundation Research Funding Opportunity
Thanks to the generous support of our patients, families, caregivers, corporate supporters, and the many friends of the Mesothelioma Applied Research Foundation, they are pleased to announce that the 2022 research funding grant cycle is now open accepting pre-application letters of intent (LOI) until 11:59 PM ET Monday, November 21, 2022. their research grant program offers $100,000 grants for two years ($50,000 per year). Please read the below before applying Additional information to be included in the LOI:
- All applications need to focus on pleural and/or peritoneal mesothelioma and should address at least one of the 2022 Areas of Interest (listed below).
- All projects must be feasible within the timeline and budgetary constraints of the current LOI.
- All other funding, overlapping and/or supplemental funding, for the proposed project should be disclosed as part of the application.
- Junior investigators with an interest in a carrier focus in mesothelioma are strongly encouraged to apply to this RFA. As part of their application, they should identify an established mesothelioma researcher as their mentor and provide a career development and mentorship plan in the context of their application.
2022 Areas of Interest (not listed in priority order):
- Novel therapies for mesothelioma for both pleural and peritoneal, especially targeted therapies, combination immunotherapy, cellular therapy, and virotherapy.
- Health-related quality of life assessment incorporating the social determinants of health (SDOH) specific to mesothelioma patient care, side effect management, mental health care impact on patient and/or caregiver outcomes, and other related topics.
- Novel strategies for screening and early detection.
- Novel strategies for risk assessment and prognosis stratification.
- Immune mediated complications of immunotherapy in mesothelioma (monitoring, early detection, and management).
- Improving personalization of therapies (gender and racial differences, targeted therapies, and predictive biomarkers).
- Mechanisms of treatment resistance/failure.
- Mesothelioma biology and etiology (disease-defining molecular pathways, cellular biology, and/or tumor microenvironment).
Participate Now
Rare Disease survey from the Canadian Organization for Rare Disorders
The Canadian Organization for Rare Disorders need input on the impact of RARE DISEASES on you and your family, as well as YOUR PERSPECTIVES on how Canadian health systems can improve access to rare disease medicines. COMPLETE THE SURVEY BY NOVEMBER 14: In ENGLISH here: https://tinyurl.com/CORD2022EnglishSurvey In FRENCH here: https://tinyurl.com/CORD2022FrenchSurvey THE SURVEY IS FOR PATIENTS AND CAREGIVERS: If you are a Canadian or resident in Canada affected by rare diseases (patients and caregivers), please take a few minutes to complete this confidential survey conducted by Ipsos Canada on behalf of the Canadian Organization for Rare Disorders (CORD). This survey will be available for completion until Monday, November 14, 2022.Participate Now
Chronic Myeloid Leukemia Treatment | Needs Assessment
OncologyEducation is evaluating their members’ needs on the topic of Chronic Myeloid Leukemia Treatment and they want to hear from you! Please complete this short survey to help us plan and develop future learning activities. All data will remain secure and confidential. Respond for a chance to win one of four $25 e-Visa Gift Cards.Participate Now

Cancer Journey Stories

Surviving Metastatic Prostate Cancer – Derek Lawrence

I first learned that I had prostate cancer from my urologist in 1995, and he told me that I actually had a very aggressive cancer. I had been to my family doctor in 1992 and 1993 for my annual checkup, which was fine; no mention was ever made to me about having a PSA blood test, but I was given a digital rectal exam. Somehow

Out-Of-Country Cancer Treatment – Thomas Vicars

Thomas Vicars was 60-years-old when he was diagnosed with prostate cancer. His prostate-specific antigen (PSA), which had been monitored throughout his 50s, had been rising for several years. After it went up to a little over 16, a biopsy confirmed prostate cancer. Thomas began looking into treatment options and wanted to go with brachytherapy, but was turned down due to his diabetes. This left surgery